choriogonadotropin alfa

choriogonadotropin alfa (OVIDREL) is an FDA-listed pharmaceutical active ingredient. Associated with Merck KGaA, Darmstadt, Germany. Route of administration: injection. Current US regulatory status: approved.

OVIDREL is a marketed brand name for choriogonadotropin alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.

choriogonadotropin alfa has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.